title: The development of metabolic risk factors after the initiation of the second line anti- retroviral therapy.
abstract: OBJECTIVE
  A Highly Active Anti-Retroviral Therapy (HAART) is accompanied with several metabolic effects like adipose redistribution and insulin resistance. In this study, we evaluated the association between a HAART and lipodystrophy.
  
  
  METHODS
  A cross sectional study, whose subjects were Human Immunodeficiency Virus (HIV) infected patients, was conducted at a tertiary care hospital in south India. Among these, 27 were on protease inhibitors for at-least 6 months and 13 were drug naive patients. The assessments of lipodystrophy, fasting blood sugar and the fasting lipid profile were done and these parameters were compared in the two groups.
  
  
  RESULTS
  The analysis of the data which was collected, showed an elevation in the total cholesterol levels in the individuals who were on the protease inhibitors versus the drug naive patients. There was a significant elevation in the Low Density Lipoprotein (LDL) cholesterol levels and a decrease in High Density Lipoprotein (HDL) cholesterol levels in the individuals who were on protease inhibitors. It was also observed that the HDL cholesterol levels decreased with an increase in the duration of the therapy. The LDL cholesterol levels increased with the duration of the therapy.
  
  
  CONCLUSIONS
  The human immunodeficiency virus infection is itself related to the metabolic complications which are aggravated on the use of second line anti retroviral therapy. Therefore, after initiating the treatment with protease inhibitors, a periodic evaluation of the serum lipid levels and the blood sugar profile should be done as a standard care.
authors.affiliation: Final year MBBS Student.
authors.forename: Apoorva
authors.initials: A
authors.lastname: Mittal
authors.forename: Basavaprabhu
authors.initials: B
authors.lastname: Achappa
authors.forename: Deepak
authors.initials: D
authors.lastname: Madi
authors.forename: Mukta N
authors.initials: MN
authors.lastname: Chowta
authors.forename: John T
authors.initials: JT
authors.lastname: Ramapuram
authors.forename: Satish
authors.initials: S
authors.lastname: Rao
authors.forename: B
authors.initials: B
authors.lastname: Unnikrishnan
authors.forename: Soundarya
authors.initials: S
authors.lastname: Mahalingam
keywords: ART; Dyslipidaemia; HAART; HIV; Metabolic syndrome
references.citation: Circulation. 1999 Aug 17;100(7):700-5
references.pmid: 10449690
references.citation: Med Clin (Barc). 2004 May 22;122(19):721-6
references.pmid: 15171905
references.citation: J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):257-75
references.pmid: 12439201
references.citation: Southeast Asian J Trop Med Public Health. 2007 Jan;38(1):69-77
references.pmid: 17539249
references.citation: Ned Tijdschr Geneeskd. 2008 May 31;152(22):1260-4
references.pmid: 18590059
references.citation: Clin Infect Dis. 2003 Oct 1;37(7):959-72
references.pmid: 13130409
references.citation: AIDS Rev. 2011 Jan-Mar;13(1):49-56
references.pmid: 21412389
references.citation: Hopkins HIV Rep. 1999 Mar;11(2):5, 15
references.pmid: 11366249
references.citation: AIDS Read. 1999 Jul;9(4):254-6, 259-60, 266-9
references.pmid: 12737115
references.citation: J Antimicrob Chemother. 2004 Jan;53(1):10-4
references.pmid: 14645323
references.citation: Diabetes Care. 2007 Jan;30(1):113-9
references.pmid: 17192343